The RT-qPCR results of this study showed that the IRAK inhibitor has no effect on the expression of BCRP, and therefore the effect of IRAK inhibitor on increased apoptotic sensitivity of BC cell lines, may be due to different regulatory signaling pathways. Here, IRAK1 is linked to breast cancer.